Maynilad Water Services, Inc.

Disclaimer: The research and recommendation below were generated by Claude Fable. Please treat this as one input for your own research — not as the sole basis for any decision to buy or sell a stock.

Last checked: July 19, 2026
Price: 19.2800
Trading status: Normal
Recommendation: Buy (starter position into the August 2026 PSEi catalyst; dividend financed, not cash-earned)Buy
Committee call: Hold
Indices: None

Analysis

MYNLD - Maynilad Water Services, Inc.

One-line summary: west-zone Metro Manila water monopoly at 8x earnings with a locked tariff path to 2027 and a dated PSEi-inclusion catalyst in August 2026, paid for with a debt-funded dividend and political repricing risk.

Snapshot


Reviewed	July 19, 2026
Index membership	None (MSCI Small Cap member since February 2026; strong-candidate PSEi entry at the August 2026 rebalance)
Price at review	P19.28 (July 17, 2026 close; 52-week range 14.02-24.45, down ~21% from the May 13, 2026 all-time high)
Recommendation	Buy (starter position into the August 2026 PSEi catalyst; size modest, the dividend is financed, not cash-earned)
Market cap	~P142.7B (7.40B shares)
Trailing P/E	7.86x
Estimated forward P/E (2026)	~8.2x (Q1 2026 net income +10.3%; tariff tranche and forex adjustment already in effect; Q2 2026 results not yet out)
Dividend (2026)	P1.14/share paid March 2026, ~5.9% yield at 19.28; policy: higher of 50% of prior-year net income or 40% of net income plus depreciation
P/B	1.35x
Debt	P98.3B total (D/E 0.93, up from 0.63 in 2021); cash P21.9B; current ratio below 1; P15B blue bonds rated PRS Aaa June 2026

Concession and tariff path

Maynilad holds the west-zone Metro Manila water concession, extended in June 2025 by ten years to January 21, 2047. It listed on November 7, 2025 at P15 (P34.3B raised, the second-largest PSE IPO ever) because the concession legally requires a 30% public float by January 2027. Control sits with Metro Pacific, DMCI, and Marubeni through a holding company; free float is ~30%.

The revenue path is unusually visible for a PSE stock: the 2022 rate rebasing set tariff tranches for 2023-2026 (the fourth took effect January 2026), a forex-adjustment increase followed in April 2026, and the 2027 rebasing is already approved at a cumulative +35.61% (lowered from 58.56% in exchange for the concession extension). Returns are capped at a regulated 12% pre-tax rate of return.

Revenue and earnings trend

Revenue P21.95B (2021), P22.88B (2022), P27.32B (2023), P33.50B (2024), P36.65B (2025). Net income P6.1B, P5.9B, P9.0B, P12.8B, P15.2B over the same years; 2025 grew 19%. Q1 2026: net income +10.3% to P4.0B on revenue +6.2%, net margin 43.9%. EBITDA margin is 69%. The growth is two engines: the approved tariff tranches and non-revenue water (system losses) falling from 39.9% (2024 average) to 30.7% (March 2026), which converts already-produced water into billed revenue. Both engines have visible runway: tariffs to 2027 are locked, and NRW in the low 30s still has room versus Manila Water's levels.

Dividend sustainability

One payment so far: P1.14/share (P8.44B, ~55% of FY2025 net income), ex March 6, paid March 18, 2026. Against earnings the payout is comfortable. Against cash it is not: free cash flow after concession capex has been negative every year since 2022, and 2025 financing inflows of P21.4B are what funded both the buildout and the dividend. This is normal utility financing during a capex supercycle, but be honest about the mechanics: the yield is being borrowed until capex peaks. The stated policy (higher of 50% of prior-year net income or 40% of net income plus depreciation) implies roughly P1.05-1.25/share on 2026 earnings if held.

ROE

10.5% (2021), 9.6% (2022), 13.8% (2023), 17.8% (2024), 16.4% (2025). Leverage did real work in that climb: D/E rose from 0.63 to over 1.0 by 2024 while ROA stayed at a steady 5-7%, consistent with the regulated 12% pre-tax return cap. The 2025 dip despite record income is the IPO equity injection (equity jumped from P75.4B to P109.8B). Expect ROE in the mid-teens, not more; the regulator defines the ceiling.

Free cash flow and the capex supercycle

Capex was P26.9B in 2025, the company's highest ever, inside a P163B program for 2023-2027 (up to P30B planned for 2026, about 30% for wastewater buildout). Under concession accounting this spending books as intangible additions, so reported operating cash flow itself turns negative: -P4.3B in 2025 against P25.3B EBITDA. Debt rose from P37.7B (2021) to P98.3B (March 2026) funding it. The investment case rests on this spend converting into the rate base that the approved 2027 tariffs remunerate. FCF should inflect as the program passes its 2026-2027 peak; until then, dividends and capex are both financed.

Capital allocation and ownership

Straightforward for a regulated utility: build the concession assets, take the approved tariffs, pay the policy dividend. No buybacks, no diversification. The Kaliwa Dam (600 MLD) is the key new water source reducing Angat Dam dependence; Maynilad is building the ~P30B Teresa treatment plant and pipelines to receive it. Financing is orderly (PRS Aaa blue bonds). The controlling group (Metro Pacific 51.3% of the holdco pre-IPO, DMCI 27.2%, Marubeni 21.5%) has run the concession since 2007; alignment with minorities is standard holdco arithmetic, with the listing itself legally mandated rather than opportunistic.

Index catalyst

Added to the MSCI Small Cap index at the February 2026 rebalance. A joint First Metro/DBS report (mid-July 2026) now puts Maynilad as a "strong candidate for early inclusion" at the August 2026 PSEi rebalance, meeting the six-month trading and liquidity thresholds and ranking around 22nd by full market cap. Of the three exit scenarios, Converge is now the clearest candidate to be dropped: it has fallen ~41% from its own P16.80 IPO price to ~P9.91, against Maynilad's ~29% gain since its P15 IPO (40% probability Converge exits, versus 30% each for ACEN and DigiPlus). PSEi inclusion forces passive buying into a ~30% float. This is the dated event the entry leans on; it is also partly priced, given the rally from the November low before the current ~21% pullback from the May high. Analyst targets have moved up since the last review, from ~P22.43 to ~P23.72-24.16.

Verdict at P19.28 (July 19, 2026)

No trigger fired since the July 14, 2026 review; price drifted from P19.56 to P19.28 on no new fundamental data (no Q2 2026 results yet, no new dividend, only a routine compliance-officer change on July 2, 2026). Buy, as a starter position, unchanged. The setup checks the rulebook's three boxes together: a dated catalyst (August 2026 PSEi decision, now firmer with Converge specifically flagged as the likely exit given its own 41% IPO-to-date decline), growing earnings (+19% in 2025, +10.3% in Q1 2026, with the 2027 tariff step already approved), and an entry that is not chasing (~21% below the May high, under 8x earnings, ~5.9% yield). The regulated cap bounds the upside, so this is a re-rating and income position, not a compounder. Size it modestly and treat the two honest weaknesses as live: the dividend is debt-funded until the capex peak passes, and the counterparty setting tariffs has torn up the deal once before (2019 review, tariff freeze, forced renegotiation). Versus MWC (6.2x P/E, same yield range, Hold on this book): MYNLD costs a P/E premium for faster growth, the NRW runway, and the index catalyst; that premium is fair, not free.

What would change the call:

Buy/add trigger: confirmed PSEi inclusion at the August 2026 announcement (add on the news if not yet gapped), or a breakout above P21 on volume, or a pullback to P16-17 (~1.1-1.2x book) with the tariff path intact.
Sell trigger: excluded from the August 2026 PSEi rebalance and price closes below P17.50; any government move to reopen concession terms or suspend an approved tariff tranche; a drought year that cuts billed volume while the dividend policy is maintained by borrowing (payout above 100% of a falling net income).

First-year listed stock, short trading history, thin coverage. Analysis, not financial advice.

Committee review (July 19, 2026)

Five investor lenses judged this page's facts independently (each fed only the numbers above, no cross-talk between lenses):

Lens	Signal	Confidence	Core argument
Ben Graham	Neutral	60	On Graham's utility yardsticks the price still passes cleanly: P/E 7.86 (under 15), P/B 1.35 (under 1.5), D/E 0.93 (inside his 2x-equity limit for utilities), earnings up every year from P6.1B to P15.2B, ~5.9% yield. What fails is conservative financing in substance and the short record: FCF negative every year since 2022, the P1.14 dividend funded by P21.4B of financing inflows while debt grew from P37.7B to P98.3B, dividend continuity of exactly one payment, and the 2019 forced renegotiation proving the earning power can be repriced politically. Nothing in the past five days changes this.
Warren Buffett	Neutral	60	The concession to 2047 is a genuine monopoly moat and 16-17% ROE at under 8x earnings is attractive on its face, but leverage is doing real work (D/E 0.63 to 0.93) and the underlying regulated ROA is capped near 12% pre-tax. Owner earnings are negative every year since 2022, so the P1.14 dividend is borrowed rather than earned. The 2019 renegotiation and the Supreme Court public-utility ruling mean the moat's economics are set by politicians at every rebasing: a fair business at a cheap price, not a wonderful one.
Michael Burry	Neutral	60	The accounting earnings (P15.2B, 42% margin, under 8x) mask a business that has generated no free cash since 2022; the dividend was paid out of P21.4B in financing inflows, so shareholders are handed back their own borrowed money at 1.35x book. Returns are legally capped at 12% pre-tax and the government has already torn up the contract once, so the "approved" +35.61% rebasing is a political promise, not a receivable. Not expensive enough to short at 7.86x, but no margin of safety in the balance sheet at this price.
Nassim Taleb	Bearish	70	Textbook fragility dressed as quality: debt up P37.7B to P98.3B in five years, current ratio below 1, FCF negative since 2022, dividend paid from fresh financing, so survival depends on continuous refinancing through a P163B capex program. The payoff is concave: returns capped at a regulated 12% while the downside is open, and the state counterparty has already defected once. A firming index catalyst does not compensate for selling volatility to a political counterparty.
Stanley Druckenmiller	Bullish	75	The trifecta is now firmer: a dated catalyst that has moved from "high-probability" to a named "strong candidate" call (First Metro/DBS, mid-July 2026), with Converge specifically identified as the likely exit given its own 41% IPO-to-date decline versus Maynilad's 29% gain; a second approved catalyst behind it (2027 rebasing at +35.61% locked, Q1 2026 net income already +10.3%); and an asymmetric entry ~21% off the high at under 8x earnings with a ~5.9% yield and analyst targets that have risen to ~P23.72-24.16 since last week. Index inclusion forces passive buying into a ~30% float; the payoff skews right into a checkable date now three weeks out. The negative FCF and D/E 0.93 are real but funded (PRS Aaa), and the 2019 repricing precedent is the tail risk, not the base case.

Conferred call: Hold (3 neutral, 1 bearish, 1 bullish; neutral-heavy split, unchanged from July 14, 2026). This is more cautious than the page's Buy: the committee's center of gravity is the financed dividend and the political counterparty, while the page leans on the dated August catalyst and locked tariff path that only Druckenmiller weights fully. The disagreement is the information: the fundamentals-only lenses see a fair regulated business at a fair price; the page's Buy is a catalyst trade with a checkable date and a defined sell trigger, which is exactly the structure the trading rulebook favors (catalyst plus earnings plus a planned cut level). If the August catalyst passes without inclusion, the page's own sell trigger converges the two views.

Shared flip trigger: Four of five lenses converge on the same threshold: the 2027 rebasing implemented in full without political interference, plus free cash flow after capex turning positive (two consecutive quarters), flips the neutral/bearish lenses bullish. The bearish flip on the other side is any government-initiated reopening of concession or tariff terms.

Review history

Date	Price	Recommendation
July 14, 2026	19.56	Buy (starter position; first review. Committee conferred Hold, weighting the financed dividend and political risk over the August catalyst)
July 19, 2026	19.28	Buy (unchanged; no new fundamentals in the window, but PSEi inclusion firmed from "high-probability" to a named strong-candidate call and analyst targets rose to ~P23.72-24.16. Committee again conferred Hold, 3 neutral/1 bearish/1 bullish, unchanged tally)